Product Images Potassium Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Potassium Chloride NDC 59651-430 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mEq K (100 Tablets Bottle) - potassium fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mEq K (100 Tablets Bottle) - potassium fig1

Each extended-release tablet contains 750 mg of USP potassium chloride equivalent to 10 mEq of potassium. It is distributed by Aurobindo Pharma USA, Inc. The usual dosage should be adjusted to the individual needs of each patient. The extended-release tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets come in a tight, light-resistant container as defined in the USP, and should be kept out of reach of children. The product is FDA-approved, and the sample preparation in the assay differs from the USP test. Full prescribing information is available in the accompanying package insert. Made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mEq K (100 Tablets Bottle) - potassium fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mEq K (100 Tablets Bottle) - potassium fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mEq K (100 Tablets Bottle) - potassium fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mEq K (100 Tablets Bottle) - potassium fig3

Each extended-release tablet contains 1500mg of Potassium chloride USP, equivalent to 20 mEg of potassium and is distributed by Aurobindo Pharma USA, Inc. The usual dosage should be adjusted according to individual patient needs, and full prescribing information can be found in the accompanying package insert. The tablets are made in India and must be kept out of reach of children. The FDA approved sample preparation for the assay differs from the USP test. The dotted lines in the overprinting zone/coding area should not be printed.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.